Authorities question individual after a traffic stop as the investigation into the missing 84-year-old enters a critical new phase.
White House Press Secretary Karoline Leavitt said President Donald Trump's initial reaction to the newly released photos and videos in the investigation into Nancy Guthrie's disappearance was “just ...
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA. The British drugmaker had been ...
Discover What’s Streaming On: We’re so back! It’s a big night on ABC as three fan favorites return with new episodes. The network’s primetime schedule starts with the fourth-season debut of Will Trent ...
PURCHASE, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), today announced that a manuscript entitled, “Phase 2 Study of Zervimesine (CT1812) in Participants with ...
PURCHASE, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), today announced that a manuscript entitled, “Phase 2 Study of Zervimesine (CT1812) in Participants with ...
Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients with central precocious puberty (CPP), potentially opening the door to a ...
Two major trials investigating the potential of the psychedelic drug LSD for reducing anxiety are set to conclude in 2026. Scientists are feeling positive after the drug’s success in an earlier-stage ...
Hosted on MSN
Why timing matters in the Ukraine crisis
This geopolitical analysis explains how and why a Russian invasion of Ukraine could unfold. Drawing on intelligence estimates, military geography, and strategic timing, the video breaks down Russia’s ...
Hosted on MSN
Eli Lilly’s phase 2 study on imlunestrant: A potential game-changer in breast cancer treatment
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is conducting a Phase 2 clinical trial titled preEMBER: A Phase 2, Open-label ...
Despite Shell’s exit from the first phase, it may consider involvement in expansion phases. Regardless, development plans for Phase 1 remain unchanged with plans for two FLNG units with combined ...
Arcus Biosciences and Gilead Sciences are discontinuing a Phase 3 trial of an experimental cancer treatment after an interim review showed the therapy was unlikely to help patients live longer. Arcus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results